Caretakers and Gatekeepers

It has now been generally accepted that the genes responsible for familial cancer syndromes can be divided into two categories, known as caretakers and gatekeepers. Caretakers are genes that control the maintenance of the genetic information integrity in each cell while gatekeepers are those genes which directly regulate tumor growth, codifying for proteins which either stimulate or inhibit proliferation, differentiation or apoptosis.

Keywords: gatekeeper genes; caretaker genes; tumor suppressor genes; cell cycle; hereditary syndromes

Figure 1. Caretaker and gatekeeper pathways.
close
 References
    Fearnidhead NS, Britton MP and Bodmer WF (2001) The ABC of APC. Human Molecular Genetics 10: 721–733.
    Ivanovich JL, Read TE, Ciske DJ, Kodner IJ and Whelan AJ (1999) A practical approach to familial and hereditary colorectal cancer. American Journal of Medicine 107: 68–77.
    Kinzler KW and Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761–763.
    Lavin MF (1999) ATM: the product of the gene mutated in ataxia telangiectasia. International Journal of Biochemistry and Cell Biology 31: 735–740.
    McClatchey AI and Cichowski K (2001) Mouse models of neurofibromatosis. Biochimica et Biophysica Acta 1471: M73–M80.
    Playford RJ (2001) Landscaper seeks remunerative position. Gut 48: 594–595.
    Scharmhorst V, Van Der Eb AJ and Jochemsen AJ (2001) WT1 proteins: functions in growth and differentiation. Gene 273: 141–161.
    Scully R and Livingston DM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429–432.
    Takahashi M (2001) The GDNF/RET signaling pathway and human diseases. Cytokine and Growth Factor Reviews 12: 361–373.
    Vogelstein B, Lane D and Levine AJ (2000) Surfing the p53 network. Nature 408: 307–310.
 Further Reading
    Bellacosa A (2001) Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death and Differentiation 8: 1076–1092.
    Berneburg M and Lehmann AR (2001) Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Advances in Genetics 43: 71–102.
    book Kinzler KW and Vogelstein B (2002) "Familial cancer syndromes: the role of caretakers and gatekeepers". In: Kinzler KW and Vogelstein B (eds.) The Genetic Basis of Human Cancer, pp. 209–210. New York: McGraw-Hill
    MacLeod K (2000) Tumor supressor genes. Current Opinion in Genetics and Development 10: 81–93.
    Prime SS, Thakker NS, Pring M, Guest PG and Paterson IC (2001) A rewiew of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncology 37: 1–16.
    Rocco JW and Sidransky D (2001) p16(MTS-1/CDKN2/INK4a) in cancer progression. Experimental Cell Research 264: 42–55.
    Russo A, Zanna I, Tubiolo C, et al. (2000) Hereditary common cancers: molecular and clinical genetics. Anticancer Research 20: 4841–4852.
    Schwab M, Claas A and Savelyeva L (2002) BRCA2: a genetic risk factor for breast cancer. Cancer Letters 175: 1–8.
    Torres J, Navarro S, Rogla I, et al. (2001) Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissue. European Journal of Cancer 37: 114–121.
 Web Links
    ePath Genew: Human Gene Nomenclature Database. Gives the full names and approved symbols for human genes with links to further information http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/searchgenes.pl
    ePath Adenomatosis polyposis coli (APC); Locus ID: 324. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=324
    ePath Ataxia telangiectasia mutated (includes complementation groups A, C and D) (ATM); Locus ID: 472. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=472
    ePath Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) (PTEN); Locus ID: 5728. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=5728
    ePath Retinoblastoma 1 (including osteosarcoma) (RB1); Locus ID: 5925. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=5925
    ePath Tumor protein p53 (Li–Fraumeni syndrome) (TP53); Locus ID: 7157. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=7157
    ePath Adenomatosis polyposis coli (APC); MIM number: 175100. OMIM: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?175100
    ePath Ataxia telangiectasia mutated (includes complementation groups A, C and D) (ATM); MIM number: 208900. OMIM: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?208900
    ePath Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) (PTEN); MIM number: 601728. OMIM: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?601728
    ePath Retinoblastoma 1 (including osteosarcoma) (RB1); MIM number: 180200. OMIM: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?180200
    ePath Tumor protein p53 (Li-Fraumeni syndrome) (TP53); MIM number: 191170. OMIM: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?191170
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Russo, Antonio, Migliavacca, Manuela, Zanna, Ines, Macaluso, Marcella, Gebbia, Nicola, and Bazan, Viviana(Jan 2006) Caretakers and Gatekeepers. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0006048]